Revenue | ₹27.19Cr |
Net Profits | ₹-59.77Cr |
Net Profit Margins | -219.82% |
Sun Pharma Advanced Research Company Ltd’s revenue jumped 29.72% since last year same period to ₹27.19Cr in the Q4 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 80.07% jump in its revenue since last 3-months.
Sun Pharma Advanced Research Company Ltd’s net profit jumped 43.5% since last year same period to ₹-59.77Cr in the Q4 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 24.83% jump in its net profits since last 3-months.
Sun Pharma Advanced Research Company Ltd’s net profit margin jumped 56.45% since last year same period to -219.82% in the Q4 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 58.25% jumped in its net profit margins since last 3-months.
The revenue for Sun Pharma Advanced Research Company Ltd in the Q4 results 2024 was ₹27.19Cr.
The net profit for Sun Pharma Advanced Research Company Ltd in the Q4 results 2024 was ₹-59.77Cr.
The net profit margin for Sun Pharma Advanced Research Company Ltd in the Q4 results 2024 was -219.82%.
The revenue for Sun Pharma Advanced Research Company Ltd in the Q4 results 2023 was ₹20.96Cr.
The net profit for Sun Pharma Advanced Research Company Ltd in the Q4 results 2023 was ₹-105.79Cr.
The net profit margin for Sun Pharma Advanced Research Company Ltd in the Q4 results 2023 was -504.72%.